| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Blum R (editor) |
Utopiates: The Use and Users of LSD-25 |
|
1965 |
| Martin WR |
The Nature of Opioid and LSD Receptors: Structural Activity Relationsh... |
QUASAR. Quantitative... |
1978 |
| Vetulani J, Bednarczyk B,... |
Inhibition of "wet shakes" during morphine abstinence by an antagonist... |
Europ. J. Pharmacol. |
1978 |
| Vetulani J, Byrska B, Rei... |
Head twitches produced by serotonergic drugs and opiates after lesion ... |
Pol. J. Pharmacol. P... |
1979 |
| Ruffig DM, Domino EF |
Effects of Selected Opioid Agonists and Antagonists on DMT- and LSD-25... |
Psychopharmacology |
1981 |
| Domino EF, Ruffing DM |
Evidence for Opioids as Partial Antagonists for Indole Hallucinogens |
Psychopharmacology B... |
1982 |
| Shearman GT, Herz A |
Non-opioid Psychotomimetic-like Discriminative Stimulus Properties Of ... |
European Journal of ... |
1982 |
| Boublik JH, Quinn MJ, Cle... |
Coffee contains potent opiate receptor binding activity |
Nature |
1983 |
| Ruffing DM, Domino EF |
Interaction of Synthetic Opioid Metenkephalin Peptide Analogs, Lilly ... |
Psychopharmacology |
1983 |
| Pfeiffer A, Brantl V, Her... |
Psychotomimesis mediated by kappa opiate receptors. |
Science |
1986 |
| Gillman MA |
Nitrous oxide, an opioid addictive agent. Review of the evidence |
Am J Med |
1986 |
| Fujimoto RA, Boxer J, Jac... |
Synthesis, opioid receptor binding profile, and antinociceptive activi... |
J Med Chem |
1989 |
| Bailey PL, Streisand JB, ... |
Differences in magnitude and duration of opioid-induced respiratory de... |
Anesth Analg |
1990 |
| Kosten TR |
Neurobiology of abused drugs. Opioids and stimulants |
J Nerv Ment Dis |
1990 |
| Gillogley KM, Evans AT, H... |
The perinatal impact of cocaine, amphetamine, and opiate use detected ... |
Am J Obstet Gynecol |
1990 |
| Bilsky EJ, Hubbell CL, De... |
MDMA produces a conditioned place preference and elicits ejaculation i... |
Pharmacol Biochem Be... |
1991 |
| Negri L, Erspamer GF, Sev... |
Dermorphin-related peptides from the skin of Phyllomedusa bicolor and ... |
Proc Natl Acad Sci U... |
1992 |
| Azolosa JL, Stitzer ML, G... |
Opioid physical dependence development: effects of single versus repea... |
Psychopharmacology (... |
1994 |
| Gallimberti L, Schifano F... |
Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate ... |
Eur Arch Psychiatry ... |
1994 |
| Smith ML, Hughes RO, Levi... |
Forensic drug testing for opiates. VI. Urine testing for hydromorphone... |
J Anal Toxicol |
1995 |
| Reid LD, Hubbell CL, Tsai... |
Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhan... |
Pharmacol Biochem Be... |
1995 |
| Drewnowski A, Krahn DD, D... |
Naloxone, an opiate blocker, reduces the consumption of sweet high-fat... |
Am J Clin Nutr |
1995 |
| Storrow AB, Magoon MR, No... |
The dextromethorphan defense: dextromethorphan and the opioid screen |
Acad Emerg Med |
1995 |
| Kintz P, Tracqui A, Mangi... |
Sweat testing in opioid users with a sweat patch |
J Anal Toxicol |
1996 |
| Reid LD, Hubbell CL, Tsai... |
Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhan... |
Pharmacol Biochem Be... |
1996 |
| Robson P |
A guide to non-opiate illicit drugs |
Practitioner |
1996 |
| Helsley S, Filipink RA, B... |
The effects of sigma, PCP, and opiate receptor ligands in rats trained... |
Pharmacol Biochem Be... |
1998 |
| Gerak LR, Brandt MR, Fran... |
Studies on benzodiazepines and opioids administered alone and in combi... |
Psychopharmacology (... |
1998 |
| Thongpradichote S, Matsum... |
Identification of opioid receptor subtypes in antinociceptive actions ... |
Life Sci |
1998 |
| Yamamoto LT, Horie S, Tak... |
Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl... |
Gen Pharmacol |
1999 |
| Walsh SL, Strain EC, Abre... |
Enadoline, a selective kappa opioid agonist: comparison with butorphan... |
Psychopharmacology (... |
2001 |
| Kavanagh P, Dunne J, Feel... |
Phenylalkylamine abuse among opiate addicts attending a methadone trea... |
Addict Biol |
2001 |
| Gervin M, Hughes R, Bamfo... |
Heroin smoking by 'chasing the dragon' in young opiate users in Irelan... |
J Subst Abuse Treat |
2001 |
| Baden LR, Horowitz G, Jac... |
Quinolones and false-positive urine screening for opiates by immunoass... |
JAMA |
2001 |
| Roth BL, Baner K, Westkae... |
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid... |
Proc Natl Acad Sci U... |
2002 |
| Takayama H, Ishikawa H, K... |
Studies on the synthesis and opioid agonistic activities of mitragynin... |
J Med Chem |
2002 |
| Tsuchiya S, Miyashita S, ... |
Effect of mitragynine, derived from Thai folk medicine, on gastric aci... |
Eur J Pharmacol |
2002 |
| Skender L,. Karacic VV, B... |
Quantitative determination of amphetamines, cocaine, and opiates in hu... |
Forensic Sci Int |
2002 |
| Mortier K, Maudens K, Lam... |
Simultaneous, quantitative determination of opiates, amphetamines, coc... |
J Chromatogr B Analy... |
2002 |
| Baker AK, Hoffmann VL, Me... |
Dextromethorphan and ketamine potentiate the antinociceptive effects o... |
Pharmacol Biochem Be... |
2002 |
| Sheffler DJ, Roth BL |
Salvinorin A: the 'magic mint' hallucinogen finds a molecular target i... |
Trends Pharmacol Sci |
2003 |
| Butelman ER, Harris TJ, K... |
The plant-derived hallucinogen, salvinorin A, produces kappa-opioid ag... |
Psychopharmacology (... |
2003 |
| Matsumoto K, Horie S, Ish... |
Antinociceptive effect of 7-hydroxymitragynine in mice: Discovery of a... |
Life Sci |
2004 |
| Chavkin C, Sud S, Jin W, ... |
Salvinorin A, an active component of the hallucinogenic sage salvia di... |
J Pharmacol Exp Ther |
2004 |
| Munro TA, Rizzacasa MA, R... |
Studies toward the pharmacophore of salvinorin A, a potent kappa opioi... |
J Med Chem |
2005 |
| Chen SL, Huang EY, Chow L... |
Dextromethorphan differentially affects opioid antinociception in rats |
Br J Pharmacol |
2005 |
| Ersche KD, Roiser JP, Cla... |
Punishment Induces Risky Decision-Making in Methadone-Maintained Opiat... |
Neuropsychopharmacol... |
2005 |
| Lee DY, Ma Z, Liu-Chen LY... |
New neoclerodane diterpenoids isolated from the leaves of Salvia divin... |
Bioorg Med Chem |
2005 |
| Gillman PK |
Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity |
Br J Anaesth |
2005 |
| Schmidt MD, Schmidt MS, B... |
Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvin... |
Synapse |
2005 |
| Campos AR, Santos FA, Rao... |
Ketamine-induced potentiation of morphine analgesia in rat tail-flick ... |
Biol Pharm Bull |
2006 |
| Ott J |
Obviation of opioid withdrawal syndrome by concomitant administration ... |
J Psychoactive Drugs |
2006 |
| Ellgren M, Spano SM, Hurd... |
Adolescent Cannabis Exposure Alters Opiate Intake and Opioid Limbic Ne... |
Neuropsychopharmacol... |
2006 |
| Robertson JR, Raab GM, Br... |
Addressing the efficacy of dihydrocodeine versus methadone as an alter... |
Addiction |
2006 |
| Butelman ER, Mandau M, Ti... |
Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocr... |
J Pharmacol Exp Ther |
2007 |
| Rothman RB, Murphy DL, Xu... |
Salvinorin A: Allosteric Interactions at the {micro}-Opioid Receptor |
J Pharmacol Exp Ther |
2007 |
| Braida D, Limonta V, Pego... |
Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa... |
Psychopharmacology (... |
2007 |
| Scheerer JR, Lawrence JF,... |
Asymmetric Synthesis of Salvinorin A, A Potent K Opioid Receptor Agoni... |
JACS |
2007 |
| Haney M |
Opioid Antagonism of Cannabinoid Effects: Differences between Marijuan... |
Neuropsychopharmacol... |
2007 |
| Mintzer IL, Eisenberg M, ... |
Treating opioid addiction with buprenorphine-naloxone in community-bas... |
Ann Fam Med |
2007 |
| Wager TD, Scott DJ, Zubie... |
Placebo effects on human {micro}-opioid activity during pain |
Proc Natl Acad Sci U... |
2007 |
| Panchal SJ, Müller-Schwef... |
Opioid-induced bowel dysfunction: prevalence, pathophysiology and burd... |
Int J Clin Pract |
2007 |
| Boyer EW, Babu KM, Macali... |
Self-treatment of opioid withdrawal with a dietary supplement, Kratom |
Am J Addict |
2007 |
| Munro TA, Duncan KK, Xu W... |
Standard protecting groups create potent and selective kappa opioids: ... |
Bioorg Med Chem |
2008 |
| Babu KM, McCurdy CR, Boye... |
Opioid receptors and legal highs: Salvia divinorum and Kratom |
Clin Toxicol (Phila) |
2008 |
| Wang Y, Chen Y, Xu W, Lee... |
2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist... |
J Pharmacol Exp Ther |
2008 |
| Prisinzano TE, Rothman RB |
Salvinorin A analogs as probes in opioid pharmacology |
Chem Rev |
2008 |
| Boyer EW, Babu KM, Adkins... |
Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa ... |
Addiction |
2008 |
| Chartoff EH, Potter D, Da... |
Exposure to the Selective kappa-Opioid Receptor Agonist Salvinorin A M... |
Neuropsychopharmacol... |
2008 |
| Dumas EO, Pollack GM |
Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspe... |
AAPS J |
2008 |
| Johnson MW, Maclean KA, R... |
Human psychopharmacology and dose-effects of salvinorin A, a kappa opi... |
Drug Alcohol Depend |
2010 |
| Krupitsky E, Nunes EV, Li... |
Injectable extended-release naltrexone for opioid dependence: a double... |
Lancet |
2011 |
| Mendelson JE, Coyle JR, L... |
Lack of effect of sublingual salvinorin A, a naturally occurring kappa... |
Psychopharmacology (... |
2011 |
| Potter DN, Damez-Werno D,... |
Repeated Exposure to the kappa-Opioid Receptor Agonist Salvinorin A Mo... |
Biol Psychiatry |
2011 |
| Rawool V, Dluhy C |
Auditory sensitivity in opiate addicts with and without a history of n... |
Noise Health |
2011 |
| Bell HJ, Azubike E, Haouz... |
The other respiratory effect of opioids: suppression of spontaneous au... |
J Appl Physiol (1985... |
2011 |
| Prozialeck WC, Jivan JK, ... |
Pharmacology of kratom: an emerging botanical agent with stimulant, an... |
J Am Osteopath Assoc |
2012 |
| Zanos P, Georgiou P, Wrig... |
The Oxytocin Analogue Carbetocin Prevents Emotional Impairment and Str... |
Neuropsychopharmacol... |
2013 |
| Ojanperä I |
Pregabalin and gabapentin in opioid overdose deaths |
|
2014 |
| Wade CL, Vendruscolo LF, ... |
Compulsive-like responding for opioid analgesics in rats with extended... |
Neuropsychopharmacol... |
2015 |
| Katselou M, Papoutsis I, ... |
AH-7921: the list of new psychoactive opioids is expanded |
Forensic Toxicol |
2015 |
| Green TC, Dauria EF, Brat... |
Orienting patients to greater opioid safety: models of community pharm... |
Harm Reduct J |
2015 |
| DePriest AZ, Puet BL, Hol... |
Metabolism and Disposition of Prescription Opioids: A Review |
Forensic Sci Rev |
2015 |
| Marshall BD, Green TC, Ye... |
Harm reduction for young people who use prescription opioids extra-med... |
Int J Drug Policy |
2016 |
| Katselou M, Papoutsis I, ... |
Old opioids, new concerns: the case of acetylfentanyl |
Forensic Toxicol |
2016 |
| Lee JD, Friedmann PD, Kin... |
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Just... |
N Engl J Med |
2016 |
| Volkow ND, McLellan AT |
Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies |
N Engl J Med |
2016 |
| Harned M, Sloan P |
Safety concerns with long-term opioid use |
Expert Opin Drug Saf |
2016 |
| Stein MD, Risi MM, Bailey... |
Linkage to Primary Care for Persons First Receiving Injectable Naltrex... |
J Subst Abuse Treat |
2016 |
| Elliott SP, Brandt SD, Sm... |
The first reported fatality associated with the synthetic opioid 3,4-d... |
Drug Test Anal |
2016 |
| Kruegel AC, Gassaway MM, ... |
Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloi... |
J Am Chem Soc |
2016 |
| Kimergård A, Deluca P, Hi... |
How Resistant to Tampering are Codeine Containing Analgesics on the Ma... |
Pain Ther |
2016 |
| Armenian P, Olson A, Anay... |
Fentanyl and a Novel Synthetic Opioid U-47700 Masquerading as Street '... |
Annals of Emergency ... |
2016 |
| Domanski K, Kleinschmidt ... |
Two cases of intoxication with new synthetic opioid, U-47700 |
Clin Toxicol (Phila) |
2016 |
| Schneir A, Metushi IG, Sl... |
Near death from a novel synthetic opioid labeled U-47700: emergence of... |
Clin Toxicol (Phila) |
2016 |
| McIntyre IM, Gary RD, Jos... |
A Fatality Related to the Synthetic Opioid U-47700: Postmortem Concent... |
J Anal Toxicol |
2016 |
| Nikolaou P, Katselou M, P... |
U-47700. An old opioid becomes a recent danger |
Forensic Toxicology |
2016 |
| Helander A, Bradley M, Ha... |
Acute skin and hair symptoms followed by severe, delayed eye complicat... |
Br J Dermatol |
2016 |
| Chang-Chien GC, Odonkor C... |
Is Kratom the New 'Legal High' on the Block?: The Case of an Emerging ... |
Pain Physician |
2017 |
| Cruz A, Domingos S, Galla... |
A unique natural selective kappa-opioid receptor agonist, salvinorin A... |
Phytochemistry |
2017 |
